Verified ProfileEN

China National Pharmaceutical Foreign Trade Corporation

Order verification — $199

Wholesale and Retail Trade · Wholesale of Pharmaceuticals and Medical Equipment

Verification dossier

China National Pharmaceutical Foreign Trade Corporation is a Chinese company based in Beijing. The company operates in the wholesale of pharmaceuticals and medical equipment sector, within the broader wholesale and retail trade industry. Established 1981, the company has been operating for 45 years.

Sinolinks tracks China National Pharmaceutical Foreign Trade Corporation as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed projects: Hazardous chemicals operation; Class III medical device operation; Pharmaceutical wholesale; Internet information services for medical devices; Road freight transport; Bonded warehouse operation; Veterinary drug operation; Pharmaceutical import and export; Class III medical equipment leasing. General projects: Food sales (pre-packaged only); Information system integration services; Technical services, development, consulting, exchange, transfer, and promotion; Software development; Health consulting services; Sales of Class II and Class I medical devices; General cargo warehousing services.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review